JP2013537915A5 - - Google Patents

Download PDF

Info

Publication number
JP2013537915A5
JP2013537915A5 JP2013530379A JP2013530379A JP2013537915A5 JP 2013537915 A5 JP2013537915 A5 JP 2013537915A5 JP 2013530379 A JP2013530379 A JP 2013530379A JP 2013530379 A JP2013530379 A JP 2013530379A JP 2013537915 A5 JP2013537915 A5 JP 2013537915A5
Authority
JP
Japan
Prior art keywords
salt
oxycodone
pharmaceutical formulation
opioid
formulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2013530379A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013537915A (ja
Filing date
Publication date
Priority claimed from US13/024,319 external-priority patent/US20110195989A1/en
Application filed filed Critical
Priority claimed from PCT/US2011/053132 external-priority patent/WO2012040651A2/en
Publication of JP2013537915A publication Critical patent/JP2013537915A/ja
Publication of JP2013537915A5 publication Critical patent/JP2013537915A5/ja
Pending legal-status Critical Current

Links

JP2013530379A 2010-09-24 2011-09-23 オピオイドの制御放出製剤 Pending JP2013537915A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US38622710P 2010-09-24 2010-09-24
US61/386,227 2010-09-24
US13/024,319 2011-02-09
US13/024,319 US20110195989A1 (en) 2010-02-09 2011-02-09 Controlled Release Formulations of Opioids
PCT/US2011/053132 WO2012040651A2 (en) 2010-09-24 2011-09-23 Controlled release formulations of opioids

Publications (2)

Publication Number Publication Date
JP2013537915A JP2013537915A (ja) 2013-10-07
JP2013537915A5 true JP2013537915A5 (pl) 2014-11-06

Family

ID=44741728

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013530379A Pending JP2013537915A (ja) 2010-09-24 2011-09-23 オピオイドの制御放出製剤

Country Status (6)

Country Link
EP (1) EP2618820A2 (pl)
JP (1) JP2013537915A (pl)
CN (1) CN103476403A (pl)
AU (1) AU2011305161A1 (pl)
CA (1) CA2812570A1 (pl)
WO (1) WO2012040651A2 (pl)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003024429A1 (en) 2001-09-21 2003-03-27 Egalet A/S Polymer release system
EP1429744A1 (en) 2001-09-21 2004-06-23 Egalet A/S Morphine polymer release system
EP1610767B1 (en) 2003-03-26 2011-01-19 Egalet A/S Morphine controlled release system
EP2155167A2 (en) 2007-06-04 2010-02-24 Egalet A/S Controlled release pharmaceutical compositions for prolonged effect
US9005660B2 (en) 2009-02-06 2015-04-14 Egalet Ltd. Immediate release composition resistant to abuse by intake of alcohol
NZ603579A (en) 2009-06-24 2014-02-28 Egalet Ltd Controlled release formulations
AU2013204592A1 (en) * 2012-04-09 2013-10-24 QRxPharma Ltd. Controlled release formulations of opioids
BR112015000150A2 (pt) 2012-07-06 2017-06-27 Egalet Ltd composições farmacêuticas dissuasoras de abuso de liberação controlada
DK3169315T3 (da) * 2014-07-17 2020-08-10 Pharmaceutical Manufacturing Res Services In Væskefyldt doseringsform til forhindring af misbrug med øjeblikkelig frigivelse
CN114515282B (zh) * 2020-11-19 2023-09-08 山东大学 Sorbic acid在制备抗冠状病毒感染药物中的应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5965161A (en) * 1994-11-04 1999-10-12 Euro-Celtique, S.A. Extruded multi-particulates
US20060240105A1 (en) * 1998-11-02 2006-10-26 Elan Corporation, Plc Multiparticulate modified release composition
US6419960B1 (en) * 1998-12-17 2002-07-16 Euro-Celtique S.A. Controlled release formulations having rapid onset and rapid decline of effective plasma drug concentrations
UA81224C2 (uk) * 2001-05-02 2007-12-25 Euro Celtic S A Дозована форма оксикодону та її застосування
US20030092724A1 (en) * 2001-09-18 2003-05-15 Huaihung Kao Combination sustained release-immediate release oral dosage forms with an opioid analgesic and a non-opioid analgesic
US20030125347A1 (en) * 2001-11-02 2003-07-03 Elan Corporation Plc Pharmaceutical composition
US8906413B2 (en) * 2003-05-12 2014-12-09 Supernus Pharmaceuticals, Inc. Drug formulations having reduced abuse potential
JP2008526846A (ja) 2005-01-05 2008-07-24 リージェンツ オブ ザ ユニバーシティ オブ ミネソタ 鎮痛性結合体
CN101151021A (zh) * 2005-03-28 2008-03-26 奥瑞克索股份公司 用于疼痛治疗的新药物组合物
WO2007087452A2 (en) 2006-01-27 2007-08-02 Theraquest Biosciences, Llc Abuse resistant and extended release formulations and method of use thereof
MX2009004965A (es) * 2006-11-07 2009-06-05 Nektar Therapeutics Al Corp Formas de dosificacion y co-administracion de un agonista de opioides y un antagonista de opioides.
WO2009143209A1 (en) * 2008-05-20 2009-11-26 Qrxpharma Limited Dual opioid pain therapy
US20110195989A1 (en) * 2010-02-09 2011-08-11 Rudnic Edward M Controlled Release Formulations of Opioids

Similar Documents

Publication Publication Date Title
JP2013537915A5 (pl)
JP2011137020A5 (pl)
JP2018109059A (ja) オピオイドアゴニストおよび隔離されているアンタゴニストを含む医薬組成物
KR102082529B1 (ko) 오피오이드-유도 유해 약역학 반응을 치료하기 위한 시스템 및 방법
JP2014504630A5 (pl)
RU2013117274A (ru) Композиции и способы для смягчения дыхательной недостаточности, вызванной передозировкой опиоидов
JP2013540807A5 (pl)
EP2793868A1 (en) Multiple unit pellet tablet formulation comprising an opioid
JP2013537915A (ja) オピオイドの制御放出製剤
JP2017513809A5 (pl)
JP2012502103A5 (pl)
WO2007146006A2 (en) Sustained release oxycodone composition with acrylic polymer and a surfactant
JP2014515405A (ja) オピオイド受容体アゴニストの逐次投与のための組成物
JP2004529959A (ja) 鎮痛剤組成物と手法
JP2020073583A (ja) ミューオピオイド受容体アンタゴニストとオピオイド剤との組み合わせ剤形
US20200155557A1 (en) Method of treating pulmonary arterial hypertension
JP2017526719A5 (pl)
US20160074387A1 (en) Systems and Methods for Attenuating Opioid-Induced Euphoria
JP2012516288A (ja) 薬物乱用抑制剤、方法および組成物
RU2011140785A (ru) Фармацевтическая композиция для лечения диабета 2 типа
US10022377B2 (en) Method of treating hypertension
ES2284657T3 (es) Combinacion de principios activos que contiene un compuesto de efecto opioide y al menos un compuesto de formula i.
WO2015089614A1 (en) Stable oral pharmaceutical composition
WO2016193456A3 (en) Opioid receptor antagonist for use in treating patients with severe constipation
RU2017144631A (ru) Повышение биодоступности лекарственных средств при терапии налтрексоном